Aspen Pharmacare (OTCMKTS:APNHY) Shares Gap Up – Should You Buy?

Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $8.14, but opened at $8.79. Aspen Pharmacare shares last traded at $8.79, with a volume of 200 shares traded.

Aspen Pharmacare Stock Up 8.0%

The firm’s 50-day moving average is $8.14 and its 200 day moving average is $7.21. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66.

About Aspen Pharmacare

(Get Free Report)

Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.

Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.

Read More

• Five stocks we like better than Aspen Pharmacare
• Dollar Tree Keeps Winning After Family Dollar Divorce
• Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
• Palomar’s High-Risk Insurance Strategy Is Paying Off Big
• Marvell’s Pullback May Be the Setup Bulls Were Waiting For

Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.